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OBJECTIVE—Physical activity is a modiﬁable risk factor for
type 2 diabetes, partly through its action on insulin sensitivity.
We report the relation between insulin sensitivity and physical
activity measured by accelerometry.
RESEARCH DESIGN AND METHODS—This is a cross-sec-
tional study of 346 men and 455 women, aged 30–60 years,
without cardiovascular disease and not treated by drugs for
diabetes, hypertension, dyslipidemia, or obesity. Participants
were recruited in 18 clinical centers from 13 European countries.
Insulin sensitivity was measured by hyperinsulinemic-euglyce-
mic clamp. Physical activity was recorded by accelerometry for
a median of 6 days. We studied the relationship of insulin
sensitivity with total activity (in counts per minute), percent of
time spent sedentary, percent of time in light activity, and activity
intensity (whether the participant recorded some vigorous or
some moderate activity).
RESULTS—In both men and women, total activity was associ-
ated with insulin sensitivity (P  0.0001). Time spent sedentary,
in light activity, and activity intensity was also associated with
insulin sensitivity (P  0.0004/0.01, 0.002/0.03, and 0.02/0.004,
respectively, for men/women) but lost signiﬁcance once adjusted
for total activity. Adjustment for confounders such as adiposity
attenuated the relationship with total activity; there were no
interactions with confounders. Even in the 25% most sedentary
individuals, total activity was signiﬁcantly associated with better
insulin sensitivity (P  0.0001).
CONCLUSIONS—Accumulated daily physical activity is a ma-
jor determinant of insulin sensitivity. Time spent sedentary, time
spent in light-activity, and bouts of moderate or vigorous activity
did not impact insulin sensitivity independently of total activity.
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hysical activity is now recognized as a major
component of type 2 diabetes prevention; cohort
studies have documented the lower risk of inci-
dent diabetes even for everyday activities such as
walking (1,2). In a post hoc analysis of the Finnish
Diabetes Prevention Study, walking for exercise for at
least 2.5 h a week in comparison with less than1hw a s
associated with a 63–69% lower risk of incident diabetes
(3). Physical activity is a complex behavior characterized
by intensity, duration, and frequency (4). Various consen-
sus groups recommend physically active lifestyles for
adults, with an accumulation of at least 30 min of moder-
ate-intensity aerobic physical activity 5 or more days a
week or vigorous-intensity aerobic physical activity for at
least 20 min 3 days a week (5). Another important dimen-
sion is the time spent in sedentary occupations (6): in the
Nurses Health Study, the number of hours spent sedentary
was related with incident diabetes even after adjusting for
total physical activity (7).
Physical activity may decrease the risk of diabetes by
increasing insulin sensitivity (1). Insulin sensitivity has
been shown to increase with physical activity, as assessed
by questionnaire (8). Objective assessment of physical
activity is now possible with unobtrusive accelerometer-
based motion sensors (9,10). The aim of this study was to
describe the relationship between insulin sensitivity, as
measured by the “gold standard” hyperinsulinemic-eugly-
cemic clamp, and habitual physical activity assessed by
accelerometer: total activity, activity intensity, and time
spent in light and sedentary activities.
RESEARCH DESIGN AND METHODS
In 2002–2004, healthy adults aged 30–60 years without diabetes, hypertension,
or dyslipidemia were recruited into the European Relationship between
Insulin Sensitivity and Cardiovascular risk (RISC) study (11,12). Each center
had ethics committee approval, and participants gave written informed
consent.
Participants had a clinical examination and an oral glucose tolerance test
and were ﬁtted with an accelerometer, which they returned 1 week later when
they presented for a hyperinsulinemic-euglycemic clamp. We report on 346
men and 455 women from 18 clinical centers, with data available on insulin
sensitivity and accelerometer-measured physical activity.
Physical activity: accelerometer. Physical activity was measured objec-
tively by a small single-axis accelerometer (Actigraph, AM7164-2.2; Computer
Science and Applications, Pensacola, FL) (9,10). The acceleration signal was
digitized with 10 samples per second, registered as counts over 1-min
intervals. The accelerometer was worn for up to 8 days on a belt in the small
of the back, from waking to bedtime except during water-based activities. We
analyzed participants with at least 3 days of data, including days when the
device was worn more than 10 h; we assumed it was not worn if there were
60 consecutive min with no counts. Accelerometer data were processed with
custom software developed for this project using SAS version 9. Data were
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DIABETES, VOL. 57, OCTOBER 2008 2613checked for spurious recording: high counts 20,000 counts/min or repeated
counts (13). Our software provided:
● total activity: average number of counts per minute when accelerometer
was worn
● activity intensity: any day when accelerometer was worn participants were
classiﬁed as having 1) some vigorous activity (5,724 counts/min for at
least 10 consecutive min), 2) some moderate activity (1,952–5,724 counts/
min for at least 10 consecutive min), or 3) neither moderate nor vigorous
activity on any day (9)
● percent time sedentary: 100 counts/min when accelerometer worn (10)
● percent time in light activity: not sedentary nor in moderate or vigorous
activity.
Anthropometric measurements. On lightly clad participants, we measured
body weight and fat-free mass by bipodal bioelectric impedance (TBF 300;
Tanita), height with a stadiometer, and waist circumference with a horizon-
tally placed tailor’s tape measure mid-way between the lower costal margin
and the iliac crest.
Characteristics. Participants were classiﬁed as never smokers, ex-smokers,
or current smokers. Family history of diabetes, menopause status, and alcohol
intake were obtained from a self-administered questionnaire.
Analytical methods. Local laboratory data were used for study inclusion
criteria. Blood collected was stored at 20°C and centrally analyzed in
Odense, Denmark, as follows. Plasma glucose was measured by the glucose
oxidase technique (Cobas Integra; Roche), and serum insulin was measured
by a speciﬁc time-resolved ﬂuroimunoassay (AutoDELFIA Insulin kit; Wallac
Oy, Turku, Finland).
Insulin sensitivity. We used a 2-h hyperinsulinemic-euglycemic clamp with
a primed-continuous infusion rate of 240 pmol/min per m
2 and a variable
dextrose infusion adjusted every 5–10 min to maintain the plasma glucose
level within 0.8 mmol/l (15%) of target glucose (4.5–5.5 mmol/l). The
procedure was standardized across centers using a written protocol and a
video demonstration, and data from the clamp were quality controlled
centrally (11,12).
Insulin sensitivity is expressed as the ratio of the M value averaged over the
ﬁnal 40 min of the clamp and normalized by fat-free mass (FFM) to the mean
plasma insulin (I) over the ﬁnal 40 min of the clamp (M/I,i nmol   min
1  
kgFFM
1   nmol/l
1) (12).
Statistical analysis. SAS version 9 was used, and statistical signiﬁcance
refers to P  0.05. Logarithms of insulin sensitivity, fasting insulin, and 2-h
plasma insulin and average number of counts per minute worn were used in
statistical testing. Data are presented transformed to the original units.
Participant characteristics are described by means  SD or % and
compared between sexes by t and 
2 tests. Mixed linear models were used to
predict insulin sensitivity adjusted for age class (40, 40–49, and 50 years),
for recruitment center as a random factor, and for sex when men and women
were combined. Mean insulin sensitivity (95% CI) is shown according to
evenly spaced classes of total activity, percent time sedentary, and activity
intensity and tested for linear trends. -Coefﬁcients quantify the relations
between insulin sensitivity and activity variables; additional adjustments were
made for other activity variables and for potential confounding factors (BMI,
waist, fasting glucose, alcohol intake, smoking, diabetes in family, and
menopause). The relations between insulin sensitivity and activity variables
were linear, as quadratic terms were nonsigniﬁcant; interactions with center,
age class, and confounders were nonsigniﬁcant.
Because sex interactions were nonsigniﬁcant, men and women were
combined. Total activity and percent time sedentary were divided into
quartiles, the mean insulin sensitivity in the resulting 16 categories was
estimated, and trend tests were used to compare across quartiles.
RESULTS
On average, men and women were, respectively, 43 and 45
years of age with BMI of 25.9 and 24.4 kg/m
2 (Table 1). The
accelerometers were worn for a median of 6 days, a total
of 89 h in men and 87 h in women. While total activity was
similar between sexes, men spent more time sedentary
and in vigorous- or moderate-intensity activity than
women (Table 1). Women spent more time than men in
light-intensity activity.
Insulin sensitivity was positively related with total ac-
tivity, with percent time spent in light activity, and with
activity intensity and negatively with time spent sedentary
in both men and women (Fig. 1 and Table 2). However,
after adjustment for total activity, the relations with insu-
lin sensitivity were no longer signiﬁcant for other activity
variables. Adjustment for other potential confounding
factors attenuated the relations between insulin sensitivity
and total activity. In the most sedentary quartile group,
those with 68% of time sedentary, there was a highly
signiﬁcant relation between insulin sensitivity and total
activity (P for trend 0.0001) (Fig. 2); for the other
quartiles, there was a trend for a positive relation (P for
trend 0.1, 0.03, and 0.2, respectively). In contrast, for a
given quartile group of total activity, there was no signif-
icant trend between insulin sensitivity and time spent
sedentary (P for trend 0.2, 0.4, 0.9, and 0.5, respectively).
DISCUSSION
This is the ﬁrst study to report the relation between
physical activity and insulin sensitivity using the gold
TABLE 1
Anthropometric, activity, and metabolic characteristics: the RISC
study
Men Women P
n 346 455
Age (years) 43  94 5  8 0.02
40 42 33
40–49 33 36 0.02
50 25 31
BMI (kg/m
2) 25.9  3.1 24.4  4.1 0.0001
Waist circumference (cm) 93  10 81  11 0.0001
Smoking (%)
Current 25 26
Ex 25 30 0.2
Never 50 44
Alcohol (g/week)* 102  102 57  67 0.0001
Family history of diabetes (%) 25 27 0.5
Menopause (%) — 26 —
Accelerometer
Days worn (n) 5.7  1.3 5.7  1.4 0.7
Time worn (h) 89  25 87  25 0.2
Total activity (average
counts/min worn)* 374  179 361  156 0.5
Percent time spent
Sedentary† 62  11 59  11 0.0001
In light activity† 36  11 39  11 0.0001
In moderate or vigorous
activity† 2  31  2 0.06
Activity intensity group (%)
Some vigorous activity‡ 21 9
Some moderate activity‡ 46 52 0.0001
Neither moderate nor
vigorous activity 23 39
Metabolic parameters
Insulin sensitivity (M/I:
mol   min
   kgFFM
1  
nmol/l
1)* 133  68 161  64 0.0001
Fasting glucose (mmol/l) 5.2  0.5 5.0  0.5 0.0001
2-h glucose (mmol/l) 5.6  1.5 5.8  1.5 0.05
Fasting insulin (pmol/l)* 34.6  17.4 32.4  18.4 0.04
2-h insulin (pmol/l)* 170  159 201  182 0.01
Data are means  SD unless otherwise indicated. *Logarithm taken
for comparing of means. †Vigorous activity, 10 consecutive min
with 5,724 counts/min; moderate activity, 10 consecutive min
with 1,952–5,724 counts/min; sedentary, 100 counts/min; light ac-
tivity, neither vigorous or moderate activity nor sedentary. ‡Some
vigorous activity, some moderate activity during the period acceler-
ometer was worn.
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objective measure of activity. Our results show that in
both men and women, total physical activity is the key
parameter positively related with insulin sensitivity: The
percent of time spent sedentary, the percent of time spent in
light-activity, and the intensity of activity were not associated
with insulin sensitivity after adjusting for total activity. The
percent of time spent in moderate or vigorous activity was
2%, with 38% in light activity. Thus, it is the accumulation of
physical activity, over the day, that appears to be the deter-
minant of insulin sensitivity. The relation between total
activity and insulin sensitivity remained after adjusting for
overall (BMI) or abdominal adiposity (waist circumference)
or other potential confounders.
In the Insulin Resistance Atherosclerosis Study, insulin
sensitivity was quantiﬁed by the frequently sampled intra-
venous glucose tolerance test and physical activity by
questionnaires; insulin sensitivity was positively associ-
ated with the frequency of vigorous physical activity and
also with the energy expended in vigorous and nonvigor-
ous activities (8). Other studies have measured physical
activity objectively but used surrogate measures of insulin
sensitivity. Total activity as measured by accelerometer
has been shown to be more strongly related to fasting
insulin than either sedentary or moderately intense activ-
ity (10). In line with our results, after 1-year follow-up in
the ProActive trial, fasting insulin was signiﬁcantly asso-
ciated with change in total body movement, as measured
by accelerometer (14). Fasting glucose has been shown to
be related to total activity (counts per minutes worn) but
not to time spent in sedentary, light-, or moderate- to
vigorous-intensity activities (15); in contrast, in the same
population, 2-h glucose was related to time spent in all
three activities (16).
Among the strengths of the RISC study is the quality
control procedure used to evaluate each clamp completed
in each clinical center (11). Also, healthy individuals from
a wide spectrum of countries were selected for the study;
none were receiving drug treatment for diabetes, hyper-
tension, lipids, or obesity, and all had a healthy clinical and
biological proﬁle.
We used accelerometer decision rules written speciﬁ-
cally for this project, and these rules may affect some of
the results (13). We assumed that the accelerometer was
not worn if 60 min was recorded with no activity, and
consequently we recorded longer percentages of seden-
tary time than other studies. For moderate or vigorous
activity, we required at least 10 min of this type of activity,
in line with current physical activity recommendations
that refer to “bouts lasting 10 or more min” (5). Activity
intensity may be underestimated because it was studied in
three groups: more than one-third of the population re-
corded no moderate or vigorous activity, thus intensity
was difﬁcult to study as a continuous variable. Further, it
has been reported that the accelerometer underestimates
higher-intensity movements (17).
Physical activity can inﬂuence insulin sensitivity in
many ways, including 1) enhancing both GLUT4-depen-
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FIG. 1. Mean insulin sensitivity (95% CI) adjusted for age and
clinical recruitment center, and characteristics of physical activity
measured by accelerometer in men and women according to: mean
number of counts/min that the accelerometer was worn (A), by
percent sedentary time (B), and by groups according to some
moderate and some vigorous intensity activity (C). The RISC study.
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muscle (18); 2) increasing skeletal muscle vascularization,
mitochondrial neobiogenesis, and eventually tissue mass
(19); 3) repartitioning intracellular fat, thereby improving
its utilization (20); and 4) fat mass loss. We and others
(21,22) have shown that aerobic exercise has a dose- and
intensity-related effect to increase insulin signaling and
glucose transporter content in skeletal muscle. Exercise
training increases insulin-stimulated glucose disposal and
GLUT-4 (SLC2A4) protein content in obese patients with
type 2 diabetes (22). High levels of sedentary time produce
the reverse effect. However, inactivity physiology may be
qualitatively different from exercise physiology, with dif-
ferent cellular mechanisms (6). For example, experimental
data from animals show that reducing low-intensity activ-
ity had a greater effect on skeletal muscle lipoprotein
lipase regulation than adding intensive exercise (6). This
parallels an Australian study that found that the negative
effects on hyperinsulinemia of 14 h per week of television
viewing were similar to the beneﬁcial effects of 2.5 h of
physical activity (walking and more vigorous activities)
(23).
Our study emphasizes that activity has beneﬁcial effects
on insulin sensitivity. In this population of men and
women aged 30–60 years, total accumulated activity was
the important factor rather than intensity of the activity.
Even in those who spent most of their time sedentary,
more movement during the day from work, household
tasks, and commuting, and also from leisure and sporting
activities, accumulated to exert a beneﬁcial effect on
insulin sensitivity, thus reducing the risk of type 2 diabetes
and other diseases associated with insulin resistance.
These results highlight the importance of even light activ-
ity, which should be taken into account in recommenda-
TABLE 2
Relations between activity parameters and insulin sensitivity*: the RISC study
Men (n  346) Women (n  455)
Men and women
(n  801)
-Coefﬁcient
(SE) P
-Coefﬁcient
(SE) P
-Coefﬁcient
(SE) P
Total activity (average number of
counts/min worn)* adjusted for:
Age and center 0.24 (0.06) 0.0001 0.24 (0.05) 0.0001 0.24 (0.04) 0.0001
Age, center, and % time sedentary 0.16 (0.09) 0.06 0.32 (0.07) 0.0001 0.25 (0.05) 0.0001
Age, center, and % time light activity 0.19 (0.07) 0.01 0.29 (0.06) 0.0001 0.24 (0.05) 0.0001
Age, center, and activity intensity (three
classes) 0.20 (0.07) 0.006 0.22 (0.05) 0.0001 0.22 (0.04) 0.0001
Age, center, and BMI 0.16 (0.06) 0.0005 0.18 (0.04) 0.0001 0.18 (0.04) 0.0001
Age, center, and waist circumference 0.13 (0.06) 0.02 0.19 (0.04) 0.0001 0.17 (0.04) 0.0001
Age, center, and fasting glucose 0.25 (0.06) 0.0001 0.25 (0.05) 0.0001 0.25 (0.04) 0.0001
Age, center, and alcohol intake* 0.24 (0.06) 0.0001 0.25 (0.04) 0.0001 0.24 (0.04) 0.0001
Age, center, and smoking 0.25 (0.06) 0.0001 0.27 (0.05) 0.0001 0.26 (0.04) 0.0001
Age, center, and diabetes in family 0.24 (0.06) 0.0001 0.24 (0.05) 0.0001 0.24 (0.04) 0.0001
Age, center, and menopause 0.24 (0.05) 0.0001
% time sedentary, adjusted for:
Age and center 0.0096 (0.0027) 0.0004 0.0049 (0.0019) 0.01 0.0069 (0.0016) 0.0001
Age, center, and total activity* 0.0047 (0.0038) 0.2 0.0042 (0.0026) 0.1 0.0005 (0.0022) 0.8
Age, center, and % time light activity 0.0269 (0.0113) 0.02 0.0193 (0.0093) 0.04 0.0213 (0.0071) 0.003
Age, center, and activity intensity (three
classes) 0.0090 (0.0027) 0.0009 0.0044 (0.0019) 0.02 0.0064 (0.0016) 0.0001
% time in light activity (% time not
sedentary, nor in moderate or vigorous
activity), adjusted for:
Age and center 0.0083 (0.0027) 0.002 0.0043 (0.0019) 0.03 0.0061 (0.0016) 0.0002
Age, center, and total activity* 0.0037 (0.0032) 0.3 0.0029 (0.0024) 0.2 0.0001 (0.0019) 0.9
Age, center, and % time sedentary 0.0177 (0.0112) 0.1 0.0150 (0.0095) 0.1 0.0149 (0.0072) 0.04
Age, center, and activity intensity (three
classes) 0.0088 (0.0027) 0.001 0.0045 (0.0019) 0.02 0.0064 (0.0016) 0.0001
Activity intensity (some moderate vs. neither
moderate nor vigorous; some vigorous
vs. neither moderate nor vigorous)
adjusted for:
Age and center 0.070 (0.067) 0.091 (0.042) 0.083 (0.036)
Age, center, and total activity* 0.22 (0.08) 0.02 0.23 (0.07) 0.004 0.22 (0.05) 0.004
0.017 (0.069) 0.6 0.028 (0.043) 0.4 0.022 (0.038) 0.3
0.088 (0.092) 0.11 (0.08) 0.085 (0.057)
Age, center, and % time sedentary 0.055 (0.066) 0.04 0.081 (0.042) 0.006 0.070 (0.036) 0.0004
0.19 (0.08) 0.22 (0.07) 0.20 (0.05)
Age, center, and % time light activity 0.064 (0.066) 0.01 0.088 (0.041) 0.003 0.078 (0.036) 0.0001
0.23 (0.08) 0.24 (0.07) 0.23 (0.05)
-Regression coefﬁcients (SEs) adjusted for age class and recruitment center and for sex where men and women combined and then
additionally adjusted, one by one, for other activity parameters and potential confounders. *Logarithm of variable.
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the general population in order to prevent diabetes.
APPENDIX
EGIR RISC Study Group investigators
RISC recruiting centers. Amsterdam, The Netherlands:
R.J. Heine, J. Dekker, S. de Rooij, G. Nijpels, W. Boorsma;
Athens, Greece: A. Mitrakou, S. Tournis, K. Kyriakopoulou,
P. Thomakos; Belgrade, Serbia: N. Lalic, K. Lalic, A. Jotic,
L. Lukic, M. Civcic; Dublin, Ireland: J. Nolan, T.P. Yeow, M.
Murphy, C. DeLong, G. Neary, M.P. Colgan, M. Hatunic;
Frankfurt, Germany: T. Konrad, H. Bo ¨hles, S. Fuellert, F.
Baer, H. Zuchhold; Geneva, Switzerland: A. Golay, E.
Harsch Bobbioni, V. Barthassat, V. Makoundou, T.N.O.
Lehmann, T. Merminod; Glasgow, Scotland: J.R. Petrie
(now Dundee), C. Perry, F. Neary, C. MacDougall, K.
Shields, L. Malcolm; Kuopio, Finland: M. Laakso, U. Sal-
menniemi, A. Aura, R. Raisanen, U. Ruotsalainen, T. Sis-
tonen, M. Laitinen, H. Saloranta; London, England: S.W.
Coppack, N. McIntosh, J. Ross, L. Pettersson, P.
Khadobaksh; Lyon, France: M. Laville, F. Bonnet (now
Rennes), A. Brac de la Perriere, C. Louche-Pelissier, C.
Maitrepierre, J. Peyrat, S. Beltran, A. Serusclat; Madrid,
Spain: R. Gabriel, E.M. Sa ´nchez, R. Carraro, A. Friera, B.
Novella; Malmo ¨, Sweden: P. Nilsson, M. Persson, G. O ¨ s-
tling, O. Melander, P. Burri; Milan, Italy: P.M. Piatti, L.D.
Monti, E. Setola, E. Galluccio, F. Minicucci, A. Colleluori;
Newcastle-upon-Tyne, England: M. Walker, I.M. Ibrahim,
M. Jayapaul, D. Carman, C. Ryan, K. Short, Y. McGrady, D.
Richardson; Odense, Denmark: H. Beck-Nielsen, P. Staehr,
K. Hojlund, V. Vestergaard, C. Olsen, L. Hansen; Perugia,
Italy: G.B. Bolli, F. Porcellati, C. Fanelli, P. Lucidi, F.
Calcinaro, A. Saturni; Pisa, Italy: E. Ferrannini, A. Natali,
E. Muscelli, S. Pinnola, M. Kozakova; Rome, Italy: G.
Mingrone, C. Guidone, A. Favuzzi, P. Di Rocco; Vienna,
Austria: C. Anderwald, M. Bischof, M. Promintzer, M.
Krebs, M. Mandl, A. Hofer, A. Luger, W. Waldha ¨usl, M.
Roden.
Project Management Board. B. Balkau, Villejuif,
France; S.W. Coppack, London, England; J.M. Dekker,
Amsterdam, The Netherlands; E. Ferrannini, Pisa, Italy; A.
Mari, Padova, Italy; A. Natali, Pisa, Italy; M. Walker,
Newcastle, England.
Core laboratories and reading centers. Lipids. Dub-
lin, Ireland: P. Gaffney, J. Nolan, G. Boran; Hormones.
Odense, Denmark: C. Olsen, L. Hansen, H. Beck-Nielsen;
Albumin:creatinine. Amsterdam, The Netherlands: A.
Kok, J. Dekker; Genetics. Newcastle-upon-Tyne, England:
S. Patel, M. Walker; Stable isotope laboratory. Pisa, Italy:
A. Gastaldelli, D. Ciociaro; Ultrasound Reading Center.
Pisa, Italy: M. Kozakova; Electrocardiogram reading.
Villejuif, France: M.T. Guillanneuf; Actigraph. Villejuif,
France: B. Balkau, L. Mhamdi; Data Management. Ville-
juif, France, Pisa and Padova, Italy: B. Balkau, A. Mari, L.
Mhamdi, L. Landucci, S. Hills. Mathematical Modeling and
Website Management. Padova, Italy: A. Mari, G. Pacini, C.
Cavaggion. Coordinating ofﬁce. Pisa, Italy: S.A. Hills, L.
Landucci, L. Mota.
Further information on the RISC study and participating
centers can be found at www.egir.org.
ACKNOWLEDGMENTS
The RISC study received the European Union Grant QLG1-
CT-2001-01252. Additional ﬁnances were provided by As-
traZeneca (Sweden). The European Group for the study of
Insulin Resistance (EGIR) is supported by Merck, Sante ´,
France. L.M. was ﬁnanced in part by a grant from La
Fondation de France.
We thank Ce ´line Lange for help with the accelerometer
data.
REFERENCES
1. Joen CY, Lokken RP, Hu FB, van Dam RM: Physical activity of moderate
intensity and risk of type 2 diabetes: a systematic review. Diabetes Care
30:744–752, 2007
2. Hu FB, Sigal RJ, Rich-Edwards JW, Colditz GA, Solomon CG, Willett WC,
Speizer FE, Manson JE: Walking compared with vigorous physical activity
and risk of type 2 diabetes in women: a prospective study. JAMA
282:1433–1439, 1999
3. Laaksonen DE, Lindstro ¨m J, Lakka TA, Eriksson JG, Niskanen L, Wikstro ¨m
K, Aunola S, Keina ¨nen-Kiukaanniemi S, Laakso M, Valle TT, Ilanne-Parikka
P, Louheranta A, Ha ¨ma ¨la ¨inen H, Rastas M, Salminen V, Cepaitis Z,
Hakuma ¨ki M, Kaikkonen H, Ha ¨rko ¨nen P, Sundvall J, Tuomilehto J,
Uusitupa M; Finnish diabetes prevention study: Physical activity in the
prevention of type 2 diabetes: the Finnish diabetes prevention study.
Diabetes 54:158–165, 2005
4. U.S. Department of Health and Human Services (DHSS): Physical Activity
and Health: A Report of the Surgeon General. Atlanta, GA: US DHSS,
Centers for Disease Control and Prevention, National Center for Chronic
Disease Prevention and Health Promotion, 1996
5. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera
CA, Heath GW, Thompson PD, Bauman A: Physical activity and public
health: updated recommendation for adults from the American College of
Sports Medicine and the American Heart Association. Med Sci Sports
Exerc 39:1423–1434, 2007
6. Hamilton MT, Hamilton DG, Zderic TW: Role of low energy expenditure
and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardio-
vascular disease. Diabetes 56:2655–2667, 2007
7. Hu FB, Li TY, Colditz GA, Willett WC, Manson JE: Television watching and
other sedentary behaviors in relation to risk of obesity and type 2 diabetes
mellitus in women. JAMA 289:1785–1791, 2003
8. Mayer-Davis EJ, D’Agostino R Jr, Karter AJ, Haffner SM, Rewers MJ, Saad
M, Bergman RN: Intensity and amount of physical activity in relation to
insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA
279:669–674, 1998
9. Freedson PS, Melanson E, Sirard J: Calibration of the Computer Science
and Applications, Inc., accelerometer. Med Sci Sports Exerc 30:777–781,
1998
10. Ekelund U, Grifﬁn SJ, Wareham NJ: Physical activity and metabolic risk in
individuals with a family history of type 2 diabetes. Diabetes Care
30:337–342, 2007
80
100
120
140
160
180
4321
2
3
4
quartiles: percent time sedentary
quartiles:
average 
counts per 
minute    53%            61%           68%
341
428
261
Insulin sensitivity:
M/I (µmol.min-1kgffm-1nM-1)
  distribution of participants according to total activity and sedentarity 
13%  6% 4% 2%  >428  quartiles: 
average 
counts per 
minute worn 
8%  7%  6% 2%  341-428 
3% 9%  8%  5%  261-341 
1% 2%  6% 16% <261 
<53% 53-61% 61-68% >  68% 
quartiles: percent time sedentary 
FIG. 2. Mean insulin sensitivity (age, sex, and recruitment center
adjusted) and physical activity measured by accelerometer (in men and
women combined) by quartiles of average number of counts/min worn
and quartiles of percent time sedentary. Table gives the distribution of
participants according to total activity and time sedentary quartiles.
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